Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Pola

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Antioxidants (Basel, Switzerland)|January 21, 2023
Non-Enzymatic Antioxidants against Alzheimer's Disease: Prevention, Diagnosis and TherapyAngelica Varesi, Lucrezia Irene Maria Campagnoli, Adelaide Carrara, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 31, 2025
Inflammation biomarkers and Alzheimer's disease: A pilot study using NULISAseqGuglielmo Di Molfetta, Ilaria Pola, Kubra Tan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersLuiza Santos Machado, Guilherme Povala, Ilaria Pola, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumLuiza Santos Machado, Guilherme Povala, Ilaria Pola, et al.
European Journal of Clinical Investigation|April 11, 2026
Prognostic Added Value of GFAP in Patients With Minor Ischemic StrokeAndrea Morotti, Mathias Sauer, Francesco Berinato, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAnna Orduña Dolado, Andrea Benedet, Alexa Pichet Binette, et al.
Nutrients|August 28, 2025
Effects of Oral Anthocyanin Supplementation on In Vitro Neurogenesis, Hippocampus-Dependent Cognition, and Blood-Based Dementia Biomarkers: Results from a 24-Week Randomized Controlled Trial in Older Adults At Risk for Dementia (ACID)Chiara de Lucia, Diego Alejandro Tovar-Rios, Khadija Khalifa, et al.
Brain Communications|May 14, 2026
A novel multiplexed biomarker panel reveals key molecular pathways in progressive multiple sclerosisChristina N Heiss, Lenka Novakova, Markus Axelsson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 26, 2026
[<sup>18</sup>F]RO948 Tau PET in early and late onset Alzheimer's disease: associations with plasma p-tau 217, atrophy and cognitionMariola Zapater-Fajari, Marco Bucci, Konstantinos Chiotis, et al.
Clinical Chemistry|November 13, 2025
Diagnostic Value of Serum p-tau217 in Alzheimer Disease: Equal to Plasma in Levels and Clinical Utility?Andrea L Benedet, Burak Arslan, Kubra Tan, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Antioxidants (Basel, Switzerland)|January 21, 2023
Non-Enzymatic Antioxidants against Alzheimer's Disease: Prevention, Diagnosis and TherapyAngelica Varesi, Lucrezia Irene Maria Campagnoli, Adelaide Carrara, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 31, 2025
Inflammation biomarkers and Alzheimer's disease: A pilot study using NULISAseqGuglielmo Di Molfetta, Ilaria Pola, Kubra Tan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersLuiza Santos Machado, Guilherme Povala, Ilaria Pola, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumLuiza Santos Machado, Guilherme Povala, Ilaria Pola, et al.
European Journal of Clinical Investigation|April 11, 2026
Prognostic Added Value of GFAP in Patients With Minor Ischemic StrokeAndrea Morotti, Mathias Sauer, Francesco Berinato, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAnna Orduña Dolado, Andrea Benedet, Alexa Pichet Binette, et al.
Nutrients|August 28, 2025
Effects of Oral Anthocyanin Supplementation on In Vitro Neurogenesis, Hippocampus-Dependent Cognition, and Blood-Based Dementia Biomarkers: Results from a 24-Week Randomized Controlled Trial in Older Adults At Risk for Dementia (ACID)Chiara de Lucia, Diego Alejandro Tovar-Rios, Khadija Khalifa, et al.
Brain Communications|May 14, 2026
A novel multiplexed biomarker panel reveals key molecular pathways in progressive multiple sclerosisChristina N Heiss, Lenka Novakova, Markus Axelsson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 26, 2026
[<sup>18</sup>F]RO948 Tau PET in early and late onset Alzheimer's disease: associations with plasma p-tau 217, atrophy and cognitionMariola Zapater-Fajari, Marco Bucci, Konstantinos Chiotis, et al.
Clinical Chemistry|November 13, 2025
Diagnostic Value of Serum p-tau217 in Alzheimer Disease: Equal to Plasma in Levels and Clinical Utility?Andrea L Benedet, Burak Arslan, Kubra Tan, et al.
Pageof 3